Upgrade Now

Company Announcements

Renamed Premier Veterinary Group

Related Companies

RNS Number : 8443G
Ark Therapeutics Group PLC
09 March 2015
 



 

ARK THERAPEUTICS GROUP PLC

 

Renamed PREMIER VETERINARY GROUP PLC

 

 NEW BOARD APPOINTMENT

 

 

London, UK, 9 March 2015 (LSE: AKT):  Further to the approval of shareholders at its General Meeting held on 11 December 2014, Ark Therapeutics Group plc (the "Company") is pleased to confirm its change of name to Premier Veterinary Group plc (LSE: PVG) with immediate effect. Trading in shares under the new name, Premier Veterinary Group plc, will start at the commencement of trading on 10 March 2015. The ISIN and SEDOL numbers will not change.

 

As at the date of this announcement, there are 13,951,773 ordinary shares of 10 pence each in issue and the total number of voting rights in the Company is 13,951,773.  This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

A further announcement regarding the change in the Company's website address to reflect the new name will be made in due course.

 

Board Appointment

 

The Company is also pleased to announce that Graham Dick BVSc MRCVS has been appointed as a Non-Executive Director with effect from 9 March 2015.

 

Mr Dick has extensive experience in the international Animal Health Sector having most recently been Country Divisional Head of the UK/Eire Animal Health Division of Bayer Healthcare. After 12 years as a partner in a thriving veterinary practice, Mr Dick joined the Ministry of Agriculture Fisheries and Food before joining Bayer Healthcare, where for over 20 years he undertook a number of senior commercial and management roles in Europe and Australasia.

 

Dominic Tonner, Chief Executive of the Company commented:

 

"We are delighted to be able to have attracted someone of Graham's calibre to join the Board and to help us build Premier Veterinary Group into a global company. He brings a wealth of experience and international contacts, and I look forward to working with him and the rest of the Board and Management team to achieve our goals."

 

 

The Company confirms that there is no information to disclose in relation to Listing Rule 9.6.13.

 

 

For further information please contact:

 

Premier Veterinary Group plc                                Tel:  +44(0)117 970 4130

 

Iain G Ross, Non-Executive Chairman

Dominic Tonner, Chief Executive Officer

 

The contents of this announcement have been prepared by and are the sole responsibility of the Company.

 

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CANUGUUGWUPAGBR

Top of Page